AstraZeneca could face limited fallout from Chinese tax probe
The drugs giant and one of its top executives are being investigated over business tactics in China, but a potential fine for one alleged offence would not break the bank…
Recent Articles
RELATED ARTICLES
-
NEWS WRAP: AstraZeneca China president assisting in investigation
AZN.US -
CSPC Pharma weighs up diet drug for bigger bottom line
1093.HK
-
Novel drugs lift Sino Biopharm earnings, easing price-cap pain
1177.HK
-
Hengrui Pharma accelerates bid for global brand status
600276.SHG
- CHINA BULLETIN: Manufacturing Déjà Vu
- CHINA BULLETIN: Blinken, Yellen Talk Up China Challenge
